Multiple Voices on Authorship and Authority in Biomedical Publications

2021 ◽  
Vol 3 (4) ◽  
Author(s):  
Lisa M. DeTora ◽  
Sabina Alam ◽  
Leslie Citrome ◽  
J. Britt Holbrook ◽  
Catherine Skobe ◽  
...  

The intersection of industry sponsorship, government regulation, academic interests, and medical journals is a core interest in biomedical research, and one that overlaps with concerns in the rhetoric of health and medicine (RHM). At stake in conversations about this intersection are authority and participation: who is and is not invited to offer opinions and, even when invited, whose opinions are taken seriously. Following, colleagues with ties to the International Society of Medical Publication Professionals (ISMPP) present their ideas in response to questions about authorship and authority posed by another, who is also an RHM scholar. The answers of medical journal editors and publications professionals employed by corporate entities largely align with the view that both authorship and authority should be determined by scientific practice and knowledge rather than power relations or politics. A philosopher who gave an invited plenary talk at the national ISMPP meeting and participated in the organization’s first white paper offers a different perspective, considering the ways that fields self-constitute in part by bounding authority and authorship.

2021 ◽  
Vol 2 (1) ◽  
pp. 18-22
Author(s):  
Takako Kojima

As potential conflicts of interest (COI) are common in biomedical research, handling related issues and managing disclosures is increasingly important. The International Committee of Medical Journal Editors (ICMJE) revised its guidance on COI in 2019 and introduced the latest version of the COI Disclosure Form in 2021. These documents provide guidance regarding COI policy for ICMJE member and non-member journals. The 2019 revision overviews the main changes in the ICMJE policy. The ICMJE prioritizes appropriate COI disclosures by authors and all others involved in scholarly publishing. Increasing the global awareness of the COI updated policies among all stakeholders is essential for strengthening ethical standing of journals.


2016 ◽  
Vol 21 (2) ◽  
pp. 44-44
Author(s):  
Jamshed Akhtar

2016 ◽  
Vol 26 (1) ◽  
pp. 2 ◽  
Author(s):  
Darren B Taichman ◽  
Joyce Backus ◽  
Christopher Baethge ◽  
Howard Bauchner ◽  
Peter W De Leeuw ◽  
...  

2013 ◽  
Vol 10 (3) ◽  
pp. 119
Author(s):  
International Committee Of Medical Journal Editors

These statements, which are published by the International Committee of Medical Journal Editors in conjunction with the Vancouver standards, cover sorne of the legal, ethical, and practical aspects of the publication of research papers, and of the comments generated by them, in biomedical journals. Pollowing a definition of what constitutes a peer-reviewed journal, the roles of journal owners and editors are described, along with those of members of an editorial board, and procedural norms are set forth in connection with conflicts of interests, retractions or corrections, fraud, and breaches of confidentiality. Arnong the last topics explored are the problems involved in the dissemination of research results by the popular media, the handling of advertising within the journal, and the simultaneous acceptance of manuscripts whose authors have arrived at opposite conclusions regarding the results of a particular study.


2015 ◽  
Vol 61 (1) ◽  
pp. 67-68
Author(s):  
Alfredo Oyola-García

La mayoría, o casi todas, las publicaciones científicas siguen las recomendaciones del International Committee of Medical Journal Editors (ICMJE). Este comité señala claramente que la publicación duplicada es una mala conducta científica(1,2), pero también lo puede ser la difamación pública, como lo hemos señalado en otros artículos.


Sign in / Sign up

Export Citation Format

Share Document